Oxidative Stress and Somavedic: What the Cell Study Can Show
is an imbalance between reactive oxygen species and antioxidant defenses. It is a standard biological concept influenced by many factors.
The study in the Somavedic library
A 2020 in-vitro paper tested Medic Amber with L-929 mouse fibroblasts and differentiated HL-60 human leukemia-derived cells during a four-hour mobile-phone and WLAN exposure.
Cell-free-space closure was 80.1 ± 7.4% with Medic Amber, 63.6 ± 7.5% in exposed unprotected cultures, and 100 ± 6.5% in unexposed controls. Neutrophil-model readouts were also higher with Medic Amber than in exposed unprotected cultures, but remained below the unexposed control.
What the study cannot establish
The experiment used cell models, not people. The protected and unprotected tests were run in sequence, and the paper reports no sham device, randomization, blinding, or dosimetry. Somavedic supplied the device.
These findings do not establish improved immunity, lower inflammation, faster recovery, more energy, or a health outcome in people. The reviewed study library also contains no user biomarker study of hs-CRP.
The accurate takeaway
The paper supports a limited statement: under the tested laboratory conditions, two cell-model readouts were higher with Medic Amber than in exposed unprotected cultures, but remained below unexposed controls. Read the full study page for the method and limits.
